PDS Biotechnology (PDSB) reported a net loss of $7.6 million, or $0.11 per basic and diluted share, for the third quarter ended September 30, 2026. The company held $15.2 million in cash and cash equivalents at quarter-end.
Third-quarter operating expenses totaled $5.9 million, down from $8.1 million a year earlier. PDS Biotech also announced the initial closing of a PIPE financing of up to $22.3 million led by Nant Capital.
- Research and development expense was $2.1 million, versus $4.6 million in the prior-year quarter.
- General and administrative expense increased to $3.8 million from $3.6 million.
- Net interest expense was $1.7 million, compared with $0.9 million a year earlier.
- The PIPE includes a contingent milestone closing tied to submission of a registrational Phase 3 trial protocol for PDS0301.
- The company reported publication of VERSATILE-002 Phase 2 results for PDS0101 with pembrolizumab in JAMA Oncology.
$PDSB Hedge Fund Activity
We have seen 36 institutional investors add shares of $PDSB stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILITIA CAPITAL MANAGEMENT LLC added 1,328,778 shares (+400.5%) to their portfolio in Q3 2026, for an estimated $997,513
- QUANTINNO CAPITAL MANAGEMENT LP added 642,177 shares (+inf%) to their portfolio in Q2 2026, for an estimated $565,822
- RENAISSANCE TECHNOLOGIES LLC added 369,146 shares (+146.4%) to their portfolio in Q3 2026, for an estimated $277,117
- MORGAN STANLEY added 310,000 shares (+7904.1%) to their portfolio in Q2 2026, for an estimated $273,141
- ACADIAN ASSET MANAGEMENT LLC added 238,835 shares (+inf%) to their portfolio in Q3 2026, for an estimated $179,293
- JANE STREET GROUP, LLC added 231,148 shares (+82.7%) to their portfolio in Q3 2026, for an estimated $173,522
- UBS GROUP AG added 224,370 shares (+2017.5%) to their portfolio in Q3 2026, for an estimated $168,434
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
